CRM three-lens brief
Evidence-based stock research on CRM. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Moved -2.21% yesterday. · Trading at 3% of its 52-week range — deep in the lower band.
- Moved -2.21% yesterday.
- Trading at 3% of its 52-week range — deep in the lower band.
- Underperforming SPY by 23.6pp over 30 days.
- Analyst mean target $268.25 — 60% above current (53 analysts).
- Debt-to-equity of 29.9 — balance-sheet-heavy.
CRM closed at $167.52 (-2.21%) as of 2026-05-13. Market cap: $137.04B. P/E (trailing) 21.5. Positives: analyst mean target $268.25 — 60% above current (53 analysts).. Concerns: moved -2.21% yesterday.; trading at 3% of its 52-week range — deep in the lower band.. Last quarter: Revenue $11.20B, net income $1.94B, free cash flow $16.37B.
Why three lenses on CRM, not one.
A single reasoning model has blind spots it doesn’t know about. We examine CRMacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/CRM" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath CRM brief"></iframe>